Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices

Professional Development

Is the time ripe for micropayments for news?

A tablet displaying abstract news columns with a small coin poised above its screen against a muted background.

“Is the time ripe for micropayments for news?” is a Professional Development seminar on 16 February 2022, held on Zoom. Dominic Young, founder and CEO of news startup Axate, discusses the challenges and opportunities of this business model in a seminar chaired by Meera Selva.

Hosted with: Psychedelic Writers Guild